Cell Therapy Human Raw Materials Market Share, Size, Trends, Industry Analysis Report, By Product (Cell Culture Media, Cell Culture Supplements, Cell Culture Sera, Reagents & Buffers, Others); By End-User; By Region; Segment Forecast, 2024- 2032
The global cell therapy human raw materials market size is expected to reach USD 19.13 billion by 2032, according to a new study by Polaris Market Research. The report “Cell Therapy Human Raw Materials Market Share, Size, Trends, Industry Analysis Report, By Product (Cell Culture Media, Cell Culture Supplements, Cell Culture Sera, Reagents & Buffers, Others); By End-User; By Region; Segment Forecast, 2024- 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The cell therapy human raw materials market is propelled by dynamic forces at the forefront of cell therapy development and manufacturing. Advances in cell therapy research, coupled with heightened investments in the field, drive the demand for specialized and high-quality raw materials. The expansion of clinical trials exploring cell therapies for various diseases amplifies the necessity for raw materials to support manufacturing processes. The increasing prevalence of chronic diseases acts as a catalyst for the development of cell therapies, consequently boosting the market for raw materials.
A notable shift towards allogeneic therapies, coupled with regulatory support, augments the demand for scalable and standardized raw materials. Collaborations and partnerships between biopharmaceutical companies and raw material suppliers streamline the supply chain. Technological innovations, global expansions of manufacturing facilities, and a growing patient demand for novel treatments further propel the growth of the cell therapy human raw materials market. Positioned at the core of cell therapy manufacturing, this market plays a pivotal role in supporting the evolving landscape of this innovative therapeutic approach.
Moreover, obstacles in the procurement and supply of premium-quality raw materials affect the market for human raw materials for cell therapy. It is still difficult for industry players to establish a reliable and morally sourced supply chain for necessary components.
The problem lies in assuring cost and widespread patient access for cell treatments, even with their potential for therapeutic benefits. A cooperative effort between manufacturers, healthcare providers, and legislators is required to effectively address these issues.
Furthermore, the cell therapy human raw materials market is under escalating regulatory scrutiny, with various regulatory and government bodies emphasizing the establishment of stringent guidelines. These guidelines encompass contamination control, biosafety, cell line authentication, and other crucial factors. The increasing emphasis on cell therapy is expected to contribute significantly to market growth over time.
Cell Therapy Human Raw Materials Market Report Highlights
In 2023, the cell culture media segment is expected to witness highest growth during forecast period owing to controlled and optimized environment with essential nutrients
Biopharmaceutical and pharmaceutical companies segment is expected to dominate the cell therapy human raw materials market during forecast period. This is attributed to technological advancements and a supportive regulatory environment
In 2023, North America accounted for the largest revenue share due to presence of major players, favorable government regulations, and rising need for groundbreaking therapeutics.
The market is highly competitive owing to the existence of market players with a global presence, including Corning Incorporated, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec, Pall Corporation., among others.
Polaris Market Research has segmented the cell therapy human raw materials market report based on product, end-user, and region:
Cell Therapy Human Raw Materials, Product Outlook (Revenue - USD Billion, 2019 - 2032)
Cell Culture Media
Cell Culture Supplements
Cell Culture Sera
Reagents & Buffers
Others
Cell Therapy Human Raw Materials, End-User Outlook (Revenue - USD Billion, 2019 - 2032)
Biopharmaceutical & Pharmaceutical Companies
CROs & CMOs
Academic & Research Institutions
Cell Therapy Human Raw Materials, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Netherlands
Spain
Russia
Asia Pacific
Japan
China
India
Malaysia
Indonesia
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Cell Therapy Human Raw Materials Market Insights
- 4.1. Cell Therapy Human Raw Materials Market – Industry Snapshot
- 4.2. Cell Therapy Human Raw Materials Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing occurrence of chronic ailments is projected to spur the product demand.
- 4.2.1.2. Favorable Regulatory Landscape is expected to drive cell therapy human raw materials market growth.
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High development cost is likely to impede the market cell therapy human raw materials growth opportunities.
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Cell Therapy Human Raw Materials Industry trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Cell Therapy Human Raw Materials Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Forklift, by Product, 2019-2032 (USD Billion)
- 5.3. Cell Culture Media
- 5.3.1. Global Cell Therapy Human Raw Materials Market, by Cell Culture Media, by Region, 2019-2032 (USD Billion)
- 5.4. Cell Culture Supplements
- 5.4.1. Global Cell Therapy Human Raw Materials Market, by Cell Culture Supplements, by Region, 2019-2032 (USD Billion)
- 5.5. Cell Culture Sera
- 5.5.1. Global Cell Therapy Human Raw Materials Market, by Cell Culture Sera, by Region, 2019-2032 (USD Billion)
- 5.6. Reagents & Buffers
- 5.6.1. Global Cell Therapy Human Raw Materials Market, by Reagents & Buffers, by Region, 2019-2032 (USD Billion)
- 5.7. Others
- 5.7.1. Global Cell Therapy Human Raw Materials Market, by Others, by Region, 2019-2032 (USD Billion)
- 6. Global Cell Therapy Human Raw Materials Market, by End-User
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 6.3. Biopharmaceutical & Pharmaceutical Companies
- 6.3.1. Global Cell Therapy Human Raw Materials Market, by Biopharmaceutical & Pharmaceutical Companies, by Region, 2019-2032 (USD Billion)
- 6.4. CROs & CMOs
- 6.4.1. Global Cell Therapy Human Raw Materials Market, by CROs & CMOs, by Region, 2019-2032 (USD Billion)
- 6.5. Academic & Research Institutions
- 6.5.1. Global Cell Therapy Human Raw Materials Market, by Academic & Research Institutions, by Region, 2019-2032 (USD Billion)
- 7. Global Cell Therapy Human Raw Materials Market, by Geography
- 7.1. Key findings
- 7.2. Introduction
- 7.2.1. Cell Therapy Human Raw Materials Market Assessment, By Geography, 2019-2032 (USD Billion)
- 7.3. Cell Therapy Human Raw Materials Market – North America
- 7.3.1. North America: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.3.2. North America: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.3.3. Cell Therapy Human Raw Materials Market – U.S.
- 7.3.3.1. U.S.: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.3.3.2. U.S.: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.3.4. Cell Therapy Human Raw Materials Market – Canada
- 7.3.4.1. Canada: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.3.4.2. Canada: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.4. Cell Therapy Human Raw Materials Market – Europe
- 7.4.1. Europe: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.4.2. Europe: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.4.3. Cell Therapy Human Raw Materials Market – UK
- 7.4.3.1. UK: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.4.3.2. UK: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.4.4. Cell Therapy Human Raw Materials Market – France
- 7.4.4.1. France: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.4.4.2. France: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.4.5. Cell Therapy Human Raw Materials Market – Germany
- 7.4.5.1. Germany: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.4.5.2. Germany: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.4.6. Cell Therapy Human Raw Materials Market – Italy
- 7.4.6.1. Italy: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.4.6.2. Italy: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.4.7. Cell Therapy Human Raw Materials Market – Spain
- 7.4.7.1. Spain: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.4.7.2. Spain: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.4.8. Cell Therapy Human Raw Materials Market – Netherlands
- 7.4.8.1. Netherlands: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.4.8.2. Netherlands: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.4.9. Cell Therapy Human Raw Materials Market – Russia
- 7.4.9.1. Russia: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.4.9.2. Russia: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.5. Cell Therapy Human Raw Materials Market – Asia Pacific
- 7.5.1. Asia Pacific: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.5.2. Asia Pacific: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.5.3. Cell Therapy Human Raw Materials Market – China
- 7.5.3.1. China: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.5.3.2. China: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.5.4. Cell Therapy Human Raw Materials Market – India
- 7.5.4.1. India: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.5.4.2. India: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.5.5. Cell Therapy Human Raw Materials Market – Malaysia
- 7.5.5.1. Malaysia: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.5.5.2. Malaysia: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.5.6. Cell Therapy Human Raw Materials Market – Japan
- 7.5.6.1. Japan: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.5.6.2. Japan: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.5.7. Cell Therapy Human Raw Materials Market – Indonesia
- 7.5.7.1. Indonesia: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.5.7.2. Indonesia: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.5.8. Cell Therapy Human Raw Materials Market – South Korea
- 7.5.8.1. South Korea: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.5.8.2. South Korea: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.6. Cell Therapy Human Raw Materials Market – Middle East & Africa
- 7.6.1. Middle East & Africa: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.6.2. Middle East & Africa: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.6.3. Cell Therapy Human Raw Materials Market – Saudi Arabia
- 7.6.3.1. Saudi Arabia: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.6.3.2. Saudi Arabia: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.6.4. Cell Therapy Human Raw Materials Market – UAE
- 7.6.4.1. UAE: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.6.4.2. UAE: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.6.5. Cell Therapy Human Raw Materials Market – Israel
- 7.6.5.1. Israel: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.6.5.2. Israel: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.6.6. Cell Therapy Human Raw Materials Market – South Africa
- 7.6.6.1. South Africa: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.6.6.2. South Africa: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.7. Cell Therapy Human Raw Materials Market – Latin America
- 7.7.1. Latin America: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.7.2. Latin America: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.7.3. Cell Therapy Human Raw Materials Market – Mexico
- 7.7.3.1. Mexico: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.7.3.2. Mexico: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.7.4. Cell Therapy Human Raw Materials Market – Brazil
- 7.7.4.1. Brazil: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.7.4.2. Brazil: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 7.7.5. Cell Therapy Human Raw Materials Market – Argentina
- 7.7.5.1. Argentina: Cell Therapy Human Raw Materials Market, by End-User, 2019-2032 (USD Billion)
- 7.7.5.2. Argentina: Cell Therapy Human Raw Materials Market, by Product, 2019-2032 (USD Billion)
- 8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
- 9. Company Profiles
- 9.1. Bio-Techne Corporation
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Catalent, Inc
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. CellGenix GmbH
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Corning Incorporated
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Lonza Group Ltd.
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Merck KGaA
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Miltenyi Biotec
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Pall Corporation (Danaher Corporation)
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. PeproTech, Inc.
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. STEMCELL Technologies Inc
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Takara Bio Inc
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. Thermo Fisher Scientific Inc
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
- 9.13. WuXi AppTec
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
- 9.14. ZenBio, Inc
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
- 9.15. RoosterBio Inc
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Recent Development
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook